SCHEMBL3479732

SCHEMBL3479732

CN1CCN(c2ccc3ccccc3c2)c2ccc(OC(F)(F)F)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.46
SCN9A Q15858 1/20 0.42
HTR6 P50406 3/20 0.42
DRD3 P35462 3/20 0.41
DRD2 P14416 3/20 0.41
KCNH2 Q12809 2/20 0.41
ALDH1A1 P00352 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38
TRPV4 Q9HBA0 4/20 0.36
HTR2A P28223 2/20 0.36
DRD1 P21728 1/20 0.36
DRD5 P21918 1/20 0.36
CCKAR P32238 1/20 0.35
FGFR4 P22455 1/20 0.35
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35
SLC6A2 P23975 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479737 0.88 KCNH2 (0.44) SCN9ADRD3DRD2KCNH2ALDH1A1
SCHEMBL3479544 0.85 ALDH1A1 (0.40) SCN9ADRD3DRD2KCNH2ALDH1A1
SCHEMBL3233430 0.85 TRPV4 (0.42) SCN9ADRD3DRD2KCNH2ALDH1A1
SCHEMBL3231984 0.84 DRD2 (0.43) SCN9ADRD3DRD2KCNH2ALDH1A1
SCHEMBL3479745 0.84 SLC6A2 (0.43) SCN9AHTR6DRD3DRD2KCNH2
SCHEMBL3225536 0.84 ALDH1A1 (0.43) SCN9ADRD3DRD2KCNH2ALDH1A1
SCHEMBL3231298 0.84 SCN9A (0.52) HTR3ASCN9AHTR6DRD3DRD2
SCHEMBL3229962 0.83 KCNH2 (0.45) SCN9ADRD3DRD2KCNH2ALDH1A1
SCHEMBL3479570 0.83 HTR1A (0.40) SCN9AHTR6DRD3DRD2KCNH2
SCHEMBL3479806 0.82 ALDH1A1 (0.41) SCN9ADRD3DRD2KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HTR3A 30/4885SCN9A 795/4885HTR6 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.